Genetic and molecular definition of complementation group D in MHC class II deficiency

被引:26
作者
Fondaneche, MC
Villard, J
Wiszniewski, W
Jouanguy, E
Etzioni, A
Le Deist, F
Peijnenburg, A
Casanova, JL
Reith, W
Mach, B
Fischer, A
Lisowska-Grospierre, B
机构
[1] Hop Necker Enfants Malad, INSERM, U429, F-15015 Paris, France
[2] Geneva Med Sch, L Jeantet Lab Mol Genet, Dept Genet & Microbiol, Geneva, Switzerland
[3] Technion Israel Inst Technol, B Rappaport Sch Med, Rambam Med Ctr, Dept Pediat, Haifa, Israel
[4] Univ Leiden Hosp, Dept Immunohematol, NL-2300 RC Leiden, Netherlands
[5] Univ Leiden Hosp, Blood Bank, NL-2300 RC Leiden, Netherlands
关键词
D O I
10.1093/hmg/7.5.879
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Four complementation groups, A, B, C and D, have been described among cell lines defective in the coordinate expression of MHC class II genes. These include cell lines established from patients affected with MHC class II deficiency and experimentally generated mutant cell lines. Group D, in contrast to the other groups, was for a long time represented only by the 6.1.6 mutant cell line. The gene responsible for the defect in this group, RFXAP recently was cloned and found to be mutated in the 6.1.6 cell line and in three patients. Here we report fusion experiments in several new HLA class II-deficient patients, completing the classification of the majority of known patients into the four complementation groups. Patients from five unrelated families were classified in complementation group D, while nine others fall into complementation groups A and B. None of the patients defined a new complementation group. Full correction of MHC class II expression was obtained in cells from patients belonging to group D by transfection with the RFXAP cDNA. The RFXAP coding region was found to be mutated in all patients. Mutations were found to be recurrent since only three different mutations have been found in the eight unrelated families reported to date.
引用
收藏
页码:879 / 885
页数:7
相关论文
共 25 条
  • [1] ROLE OF MHC GENE-PRODUCTS IN IMMUNE REGULATION
    BENACERRAF, B
    [J]. SCIENCE, 1981, 212 (4500) : 1229 - 1238
  • [2] CLASS-II-ANTIGEN-NEGATIVE PATIENT AND MUTANT B-CELL LINES REPRESENT AT LEAST 3, AND PROBABLY 4, DISTINCT GENETIC-DEFECTS DEFINED BY COMPLEMENTATION ANALYSIS
    BENICHOU, B
    STROMINGER, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) : 4285 - 4288
  • [3] CHARRON D, 1979, P NATL ACAD SCI USA, V76, P8567
  • [4] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [5] COOPER DN, 1991, HUM GENET, V87, P409
  • [6] A TRANS-ACTING CLASS-II REGULATORY GENE UNLINKED TO THE MHC CONTROLS EXPRESSION OF HLA CLASS-II GENES
    DEPREVAL, C
    LISOWSKAGROSPIERRE, B
    LOCHE, M
    GRISCELLI, C
    MACH, B
    [J]. NATURE, 1985, 318 (6043) : 291 - 293
  • [7] Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains
    Douhan, J
    Hauber, I
    Eibl, MM
    Glimcher, LH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) : 1063 - 1069
  • [8] RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency
    Durand, B
    Sperisen, P
    Emery, P
    Barras, E
    Zufferey, M
    Mach, B
    Reith, W
    [J]. EMBO JOURNAL, 1997, 16 (05) : 1045 - 1055
  • [9] SEQUENCES AND FACTORS - A GUIDE TO MHC CLASS-II TRANSCRIPTION
    GLIMCHER, LH
    KARA, CJ
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1992, 10 : 13 - 49
  • [10] Griscelli C, 1989, Immunodefic Rev, V1, P135